KROS FY 2020 Earnings — Keros Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

KROSKeros Therapeutics, Inc.

$414M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$605,000

Operating Income

-$47M

Net Income

-$45M

EPS (Diluted)

$-2.93

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$269M

Total Liabilities

$8M

Stockholders' Equity

$262M

Cash & Equivalents

$266M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$10M	-100.0%
Gross Profit	-$605,000	-$7M	+91.8%
Operating Income	-$47M	-$11M	-341.7%
Net Income	-$45M	-$12M	-267.5%